Page last updated: 2024-08-22

furylfuramide and Recrudescence

furylfuramide has been researched along with Recrudescence in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Berte, B; Bisbal, F; De Becker, B; De Potter, T; Demolder, A; Duytschaever, M; El Haddad, M; Johannessen, A; Knecht, S; O'Neill, L; Polain de Waroux, JL; Rivero-Ayerza, M; Scherr, D; Tavernier, R; Vijgen, J; Wolf, M	1

Trials

1 trial(s) available for furylfuramide and Recrudescence

Article	Year
No Effect of Continued Antiarrhythmic Drug Treatment on Top of Optimized Pulmonary Vein Isolation in Patients With Persistent Atrial Fibrillation: Results From the POWDER-AF2 Trial. Circulation. Arrhythmia and electrophysiology, 2023, Volume: 16, Issue:11 Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Furylfuramide; Humans; Powders; Prospective Studies; Pulmonary Veins; Quality of Life; Recurrence; Tachycardia; Treatment Outcome	2023

Article

Year

No Effect of Continued Antiarrhythmic Drug Treatment on Top of Optimized Pulmonary Vein Isolation in Patients With Persistent Atrial Fibrillation: Results From the POWDER-AF2 Trial.

Circulation. Arrhythmia and electrophysiology, 2023, Volume: 16, Issue:11

Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Furylfuramide; Humans; Powders; Prospective Studies; Pulmonary Veins; Quality of Life; Recurrence; Tachycardia; Treatment Outcome

2023